PTP4A2 and ovarian carcinoma: Studies with patient-derived tumor samples indicate a high level of expression of protein-tyrosine phosphatase 4A (PTP4A, also known as PRL) family members, and particularly PTP4A3 in ovarian cancers [3-6].